AZ beats expectations but is strategy sustainable?
This article was originally published in Scrip
Executive Summary
AstraZeneca has beaten consensus expectations for the first quarter of 2015 but analysts are questioning the big pharma's methods to meet targets and the sustainability of its strategies.